ResApp (ASX: RAP) – Webinar Presentation
Tony Keating – CEO & Managing Director – ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.
Read MoreTag: RAP
ResApp (ASX: RAP) – Webinar Presentation
Dr Tony Keating – CEO & MD – ResApp is developing the world’s first COVID-19 instant screening test that will use cough sounds to indicate the presence of a COVID-19 infection.
Read MoreDiagnosing COVID Via a Smartphone App
ResApp Health (ASX: RAP) is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.
Read MoreDigital health solutions for respiratory disease
Brian leedman – Executive Director & Corporate Affairs – ResApp is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.
Read MoreResapp Health – ShareCafe Hidden Gems Webinar Presentation
Presenter – Tony Keating (CEO) – ResApp Health is developing healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease on smartphones without the need for additional hardware.
Read MoreRAP – Morgans rates the stock as Add
The company has received Therapeutic Goods Administration approval for its paediatric cough diagnostic. This follows CE Mark approval for both children and adults which allows the company to market the device across Europe.
Read MoreSmall Cap Biotech’s Under The Microscope
After some earlier positive trial results, the biotech sector is seeking treatment after some less than impressive results. But does value remain for investors?
Read MoreResapp Searches For Remedy
The best-performing ASX stock of 2015, ResApp has joined the list of biotech stocks suffering an embarrassing – and surprising – clinical setback.
Read More
